Exosome-Mediated Regulation of Re-Epithelialization and Epithelial–Mesenchymal Plasticity in Diabetic Cutaneous Wounds: Current Advances and Translational Perspectives
Skin · 2026
DOI: 10.2738/skin.2026.0035 ↗Kurz gefasst
Fachartikel in der Zeitschrift Skin, 2026. Verfasst von Xu Han und 4 weiteren Autor:innen. Die Arbeit nennt 70 Literaturangaben.
Abstract (Originalsprache)
Diabetic cutaneous wounds, particularly diabetic foot ulcers, are common and refractory chronic complications of diabetes. Their impaired healing is closely associated with persistent inflammation, oxidative stress, insufficient angiogenesis, dysregulated extracellular matrix (ECM) remodeling, and defective re-epithelialization. Re-epithelialization requires keratinocytes to undergo coordinated, stage-dependent transitions among activation, migration, proliferation, redifferentiation, and barrier reconstruction. Compared with the classical concept of epithelial–mesenchymal transition, epithelial–mesenchymal plasticity (EMP) more accurately reflects the transient, reversible, and intermediate phenotypic states adopted by keratinocytes during cutaneous wound repair. Exosomes/small extracellular vesicles (sEVs) may support this process by exerting functional effects on keratinocyte repair programs and indirectly remodeling inflammatory, vascular, oxidative, and ECM microenvironments. However, most available studies assess wound closure, histological re-epithelialization, angiogenesis, inflammation, or collagen deposition, and direct evidence linking exosome/sEV treatment to coordinated EMP-associated state transitions, epithelial redifferentiation, and barrier recovery in diabetic wound keratinocytes remains limited. This review therefore reinterprets current exosome/sEV evidence through a keratinocyte-centered framework of “EMP imbalance–exosome-mediated intercellular communication–wound microenvironment remodeling.” We distinguish direct EMP evidence from functional keratinocyte effects, indirect microenvironmental support, and mechanistic inference, and discuss engineered vesicles, local delivery systems, evidence maturity, and translational risks. This framework clarifies both the therapeutic promise and the current evidentiary boundaries of exosome/sEV-based strategies for diabetic wound re-epithelialization.
Zitieren
APA
Han, X., Jin, X., Sun, T., Zhou, D., & Wang, H. (2026). Exosome-Mediated Regulation of Re-Epithelialization and Epithelial–Mesenchymal Plasticity in Diabetic Cutaneous Wounds: Current Advances and Translational Perspectives. Skin. https://doi.org/10.2738/skin.2026.0035
Vancouver
Han X, Jin X, Sun T, Zhou D, Wang H. Exosome-Mediated Regulation of Re-Epithelialization and Epithelial–Mesenchymal Plasticity in Diabetic Cutaneous Wounds: Current Advances and Translational Perspectives. Skin. 2026. doi:10.2738/skin.2026.0035
BibTeX
@article{Han2026,
author = {Han, Xu and Jin, Xiao and Sun, Te and Zhou, Dapeng and Wang, Hongyi},
title = {Exosome-Mediated Regulation of Re-Epithelialization and Epithelial–Mesenchymal Plasticity in Diabetic Cutaneous Wounds: Current Advances and Translational Perspectives},
journal = {Skin},
year = {2026},
doi = {10.2738/skin.2026.0035}
}
EUVIMED